A web-based tool to help predict submucosal invasive cancer in large non-pedunculated colorectal polyps
Official title: Multi-centre Evaluation of a Novel Clinical Decision Support Tool to Predict Submucosal Invasive Cancer Within Large Non-Pedunculated Colorectal Polyps - A Prospective Study
Run by University Hospital, Ghent · NCT07705880 · Data updated 2026-11-12
A web-based decision aid is being tested to see if it can help endoscopists predict cancer invasion in large non-pedunculated colorectal polyps during live colonoscopies.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 886 (estimated) |
| Sponsor | University Hospital, Ghent Academic / other |
| Locations | 1 site (Ghent) |
| Status | Recruiting |
| Started | October 1, 2022 |
| Main results expected | September 2030 |
| Study ends | September 30, 2030 |
| Registry record updated | September 21, 2026 |
| Trial ID | NCT07705880 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Endoscopists of varying experience performing colonoscopies on patients with large non-pedunculated polyps (≥20 mm) who are eligible for polyp assessment during standard colonoscopy.
✕Probably not a fit
Patients whose polyps do not harbor submucosal invasion or who are not in settings where the tool improves decision-making may not experience a benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a prospective, multi-center observational study across eight centers in Europe and Israel. It evaluates a freely accessible web-based clinical decision support tool that uses standard endoscopic imaging to identify submucosal invasive cancer within large non-pedunculated polyps (≥20 mm). Endoscopists of varying experience assess polyps with the tool during live procedures, after which they receive targeted training and re-assess, enabling a pre-post evaluation of diagnostic accuracy. The tool relies on established risk factors such as demarcated area, size, Paris classification, location, and granularity. The trial aims to determine whether the tool improves decision-making about endoscopic treatment versus referral for surgery, in non-tertiary practice settings.
Why it matters
Potential benefit: If successful, the tool could improve accuracy in identifying invasive cancer, potentially guiding treatment choices and reducing unnecessary surgeries.
How similar studies have gone: Prior endoscopic classification systems are complex and underused; this study tests a simpler, web-based approach with ongoing evaluation of its accuracy.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Endoscopist participants * Gastrointestinal endoscopists of varying abilities and grades * Endoscopists who have not previously encountered the clinical decision support tool Patient participants * Referred for colonoscopy with appropriate bowel preparation * Colorectal polyp \>=20mm in size detected or referred for resection * Non-pedunculated morphology * Non-sessile serrated morphology * Signed informed consent for the procedure and trial participation Exclusion Criteria: Endoscopist participants: * Does not consent to inclusion * Does not undergo the learning intervention * No connection with endoscopy in gastroenterology Patient participants: * Does not consent to data collection for the study * Video of inadequate quality as per opinion of the principal investigator
Where it's running
-
UZ Gent
Ghent, Belgium Recruiting
Study contacts
- Study coordinator: David Tate
- Email: studiestissue.resectie@uzgent.be
- Phone: +3293321063
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Comparing two methods for detecting colorectal polyps during colonoscopy
This study is testing which method, Linked-color imaging or indigo carmine chromoendoscopy, is better at finding colorectal polyps during colonoscopy for people aged 45 to 85 who have had polyps before or have related symptoms.
-
Biomarkers in Colorectal Cancer: A Longitudinal Study Using Biobanks and Blood Samples
This study tests whether clinical and molecular biomarkers from tumor tissue and blood can predict treatment response, recurrence, and survival in adults with colorectal cancer undergoing surgery.
-
Prehabilitation with Resistance, Aerobic, or Both Before Colorectal Surgery
Four pre-surgery exercise options (resistance, aerobic, both, or none) will be tested to see which best reduces complications after colorectal cancer surgery.
-
ctDNA blood test to spot buried cancer after surgery or treatment in colorectal cancer
A blood test that looks for specific KRAS mutations in circulating tumor DNA to see if colorectal cancer has left residual disease or is likely to relapse.
-
Multimodal Survival Predictor for Colorectal Liver Metastases After Surgery
Researchers are testing a tool that combines MRI-derived tumor features with clinical data to predict survival after surgery for colorectal liver metastases.
-
Methylscape test in body fluids for multi-cancer detection in Colombia
A simple blood, urine, or saliva test called Methylscape is being tested to see if it can detect multiple cancers and identify where the signal is coming from, using people with cancer and healthy volunteers in Colombia.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.